MyHealthChecked (MHC) Competitors

MyHealthChecked (LON:MHC) and Novacyt (LON:NCYT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, community ranking, analyst recommendations, valuation and media sentiment.

Does the media favor MHC or NCYT?

In the previous week, Novacyt had 1 more articles in the media than MyHealthChecked. MarketBeat recorded 1 mentions for Novacyt and 0 mentions for MyHealthChecked. Novacyt's average media sentiment score of 0.76 beat MyHealthChecked's score of 0.00 indicating that Novacyt is being referred to more favorably in the news media.

Company	Overall Sentiment
MyHealthChecked	Neutral
Novacyt	Positive

Which has more risk & volatility, MHC or NCYT?

MyHealthChecked has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Comparatively, Novacyt has a beta of -1.86, indicating that its stock price is 286% less volatile than the S&P 500.

Do institutionals and insiders have more ownership in MHC or NCYT?

3.1% of MyHealthChecked shares are owned by institutional investors. Comparatively, 0.1% of Novacyt shares are owned by institutional investors. 53.6% of MyHealthChecked shares are owned by company insiders. Comparatively, 3.1% of Novacyt shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Does the MarketBeat Community believe in MHC or NCYT?

Novacyt received 36 more outperform votes than MyHealthChecked when rated by MarketBeat users.

Company	Underperform	Outperform
MyHealthChecked	N/A	N/A
Novacyt	Outperform Votes 36 58.06%	Underperform Votes 26 41.94%

Which has better valuation and earnings, MHC or NCYT?

MyHealthChecked has higher earnings, but lower revenue than Novacyt. MyHealthChecked is trading at a lower price-to-earnings ratio than Novacyt, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MyHealthChecked	£9.43M	0.73	-£1.04M	-£2.00	-6.63
Novacyt	£18.12M	1.48	-£36.80M	-£54.44	-0.71

Is MHC or NCYT more profitable?

MyHealthChecked has a net margin of -11.06% compared to Novacyt's net margin of -203.06%. MyHealthChecked's return on equity of -12.80% beat Novacyt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MyHealthChecked	-11.06%	-12.80%	-8.18%
Novacyt	-203.06%	-47.73%	-27.98%

Summary

MyHealthChecked beats Novacyt on 8 of the 14 factors compared between the two stocks.